Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DexCom, Inc. (DXCM) vs Roblox Corp (RBLX) Price & Performance

DexCom, Inc.Trade
Roblox CorpTrade

Price performance (Past 24H)

Key statistics

DexCom, Inc. vs Roblox Corp — how do they compare? DexCom, Inc. trades at $84.14 (market cap $31.86B), while Roblox Corp trades at $47.92 (market cap $32.52B). The key difference: DexCom, Inc. and Roblox Corp are close in size by market cap, and DexCom, Inc. is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Roblox Corp for 93 Days on average.

DXCMRBLX
Market Cap
$31.86B$32.52B
Volume
3,607,07014,552,045
Sector
HealthTechnology
52-Week High
$92.34$138.56
52-Week Low
$54.84$35.54
Typical Hold Time
62 Days93 Days
Enterprise Value
$31.32B$31.34B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DexCom, Inc.

DexCom (DXCM) trades at $84.03, down 0.32% on the day, with strong fundamental performance including three consecutive quarterly EPS beats and robust 20.12% net income margin. The stock shows bearish technical signals with price near pivot point support at $84, while analyst consensus remains overwhelmingly positive with 81% buy ratings and $95.07 price target representing 13% upside potential. Recent news highlights expansion opportunities in Type 2 diabetes care and executive promotions.

DXCM presents a compelling growth story with expanding profit margins and consistent earnings outperformance, though technical weakness and premium valuation create near-term headwinds. The company's leadership in continuous glucose monitoring and Type 2 diabetes market expansion provide long-term catalysts, while competition and reimbursement risks require monitoring.

Roblox Corp

Roblox (RBLX) trades at $48.74, up 5.02% in the last session, with technical indicators showing bearish momentum despite recent price strength. The company continues to demonstrate strong revenue growth, reaching $4.89 billion in 2025, but remains unprofitable with a net income margin of -17.61%. Recent analyst downgrades from Jefferies highlight concerns about bookings growth, while AI development tools show potential for long-term platform expansion.

The stock faces near-term headwinds from bearish technical signals and valuation concerns, but strong revenue growth and AI innovation provide long-term potential. Key risks include persistent profitability challenges and competitive pressures in the gaming sector, while analyst consensus suggests modest upside to the $50.85 price target.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DXCM
100% Buy0% Sell
Avg holding period · 62 Days
RBLX
50% Buy50% Sell
Avg holding period · 93 Days

Top news

Latest headlines on both assets

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Read more on DXCM →

About Roblox Corp

Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.

Read more on RBLX →